NA-HQ

ISPOR Spain Chapter “Post ISPOR Conference”

May 18, 2023

NA-HEORupdates3

The First Joint Roundtable on Health Technology Assessment Between Ukraine and NICE, UK

May 17, 2023

NA-HEORupdates3

Integrating Digital Health Care – How Can Patient Reported Outcomes Data Link Up?

Feb 13, 2023

NA-global

Health Policy Updates from Europe, Middle East and Africa Region

Feb 13, 2023

NA-News

Economic Evaluation Guidelines in Middle East and North Africa: From Development to Implementation

Feb 13, 2023

NA-global

Health Insurance in Africa: Sustainability in Focus

Feb 13, 2023

NA-ISPOR

ISPOR Health Science and Policy Initiatives Updates - February 2023

Feb 13, 2023

NA-HEORupdates3

ISPOR Spain Chapter Explores the Future of HTA: New Regulation and Market Access

Feb 10, 2023

NA-HQ

ISPOR Italy Rome Chapter 8th Annual Conference

Feb 10, 2023

NA-HEORupdates3

ISPOR South Africa 11th Annual Conference 2022: Highlights

Feb 10, 2023

NA-ISPOR

Highlights from the ISPOR 2022 Patient Representative Roundtable - Europe

Feb 10, 2023

NA-chapters

ISPOR Hosts an HTA Roundtable for the Middle East and Africa

Feb 10, 2023

NA-News

ISPOR Health Science and Policy Initiatives News

Nov 17, 2022

NA-HQ

Off-Label Use of Immune Checkpoint Inhibitors: Is it Really Beneficial?

Nov 17, 2022

NA-News

Uganda Receives Three Experimental Ebola Vaccines

Nov 1, 2022

NA-global

A Review of COVID-19 Population Modeling Approaches

Nov 1, 2022

NA-Policy

Collaboration on HTA within the EU - What does it Mean for CEE Countries?

Aug 16, 2022

NA-ISPOR

ISPOR Science and Health Policy Initiatives - August 2022

Aug 15, 2022

NA-News

Highlights of the 1st Congress of ISPOR Rome for Future Group (GIRF)

Aug 11, 2022

NA-News

ISPOR Slovakia published 2nd edition of the Guidelines for Preparation of Pharmacoeconomic Analysis

May 5, 2022

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×